Skip to main content
Erschienen in: PharmacoEconomics 3/2003

01.02.2003 | Original Research Article

A Meta-Analysis of Quality-of-Life Estimates for Stroke

verfasst von: Dr Tammy O. Tengs, Ting H. Lin

Erschienen in: PharmacoEconomics | Ausgabe 3/2003

Einloggen, um Zugang zu erhalten

Abstract

Background: Researchers performing cost-effectiveness analyses often incorporate quality-of-life (QOL) estimates.
Objective: To aid analysts, we performed a meta-analysis to estimate quality of life for minor, moderate, and major stroke and assessed the relative importance of study design characteristics in predicting the quality of life of patients with stroke.
Methods: Through a systematic search we identified 20 articles reporting 53 unique QOL weights for stroke. Each article was read and QOL weights and study characteristics were recorded. We used a hierarchical linear model (HLM) to perform a meta-regression. The model included severity of stroke, elicitation method, respondents, and QOL scale bounds as explanatory variables.
Results: Severity of stroke (p < 0.0001) and the bounds of the scale (p = 0.0015) were significant predictors of quality of life, while the elicitation method and respondents were not. Pooling QOL weights using the HLM model, we estimated a quality of life of 0.52 for major stroke, 0.68 for moderate stroke, and 0.87 for minor stroke if the time trade-off method is used to assess quality of life from community members when the scale bounds range from death to perfect health.
Conclusions: We found no systematic difference in stroke QOL weights depending on elicitation method or respondents. However, quality of life is sensitive to the bounds of the scale. Because the pooled QOL estimates reported here are based on a comprehensive review of the QOL literature for stroke, they should be of great use to researchers performing cost-utility analyses of interventions designed to prevent or treat stroke, or where stroke is a possible side effect of therapy.
Literatur
1.
Zurück zum Zitat Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996 Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
2.
Zurück zum Zitat Tengs TO, Yu M, Luistro E. Health-related quality of life estimates after stroke: a comprehensive review. Stroke 2001; 32: 964–72PubMedCrossRef Tengs TO, Yu M, Luistro E. Health-related quality of life estimates after stroke: a comprehensive review. Stroke 2001; 32: 964–72PubMedCrossRef
3.
Zurück zum Zitat Tengs T, Wallace A. One-thousand health-related quality of life estimates. Med Care 2000; 38 (6): 583–637PubMedCrossRef Tengs T, Wallace A. One-thousand health-related quality of life estimates. Med Care 2000; 38 (6): 583–637PubMedCrossRef
4.
Zurück zum Zitat Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes: comparison of assessment methods. Med Decis Making 1984; 4: 315–29PubMedCrossRef Read JL, Quinn RJ, Berwick DM, et al. Preferences for health outcomes: comparison of assessment methods. Med Decis Making 1984; 4: 315–29PubMedCrossRef
5.
Zurück zum Zitat Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients’ well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45 (5): 505–12PubMedCrossRef Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients’ well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45 (5): 505–12PubMedCrossRef
6.
Zurück zum Zitat Gabriel SE, Kneeland TS, Melton LJ, et al. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999; 19 (2): 141–8PubMedCrossRef Gabriel SE, Kneeland TS, Melton LJ, et al. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999; 19 (2): 141–8PubMedCrossRef
7.
Zurück zum Zitat Boyd NF, Sutherland HJ, Heasman KZ, et al. Whose utilities for decision analysis? Med Decis Making 1990; 10 (1): 58–67PubMedCrossRef Boyd NF, Sutherland HJ, Heasman KZ, et al. Whose utilities for decision analysis? Med Decis Making 1990; 10 (1): 58–67PubMedCrossRef
8.
Zurück zum Zitat Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978; 31 (11): 697–704PubMedCrossRef Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978; 31 (11): 697–704PubMedCrossRef
9.
Zurück zum Zitat Fryback DG, Lawrence Jr WF. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making 1997; 17 (3): 276–84PubMedCrossRef Fryback DG, Lawrence Jr WF. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments. Med Decis Making 1997; 17 (3): 276–84PubMedCrossRef
10.
Zurück zum Zitat Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35 (4): 629–37PubMedCrossRef Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a meta-analytic comparison. Am J Kidney Dis 2000; 35 (4): 629–37PubMedCrossRef
11.
Zurück zum Zitat Dijkers M. Quality of life after spinal cord injury: a meta analysis of the effects of disablement components. Spinal Cord 1997; 35 (12): 829–40PubMedCrossRef Dijkers M. Quality of life after spinal cord injury: a meta analysis of the effects of disablement components. Spinal Cord 1997; 35 (12): 829–40PubMedCrossRef
12.
Zurück zum Zitat Kinney MR, Burfitt SN, Stullenbarger E, et al. Quality of life in cardiac patient research: a meta-analysis. Nurs Res 1996; 45 (3): 173–80PubMedCrossRef Kinney MR, Burfitt SN, Stullenbarger E, et al. Quality of life in cardiac patient research: a meta-analysis. Nurs Res 1996; 45 (3): 173–80PubMedCrossRef
13.
Zurück zum Zitat Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res 1999; 8 (5): 447–59PubMedCrossRef Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res 1999; 8 (5): 447–59PubMedCrossRef
15.
Zurück zum Zitat Neumann PJ, Zinner DE, Wright JC. Are methods for estimating QALYs in cost-effectiveness analyses improving? Med Decis Making 1997; 17 (4): 402–8PubMedCrossRef Neumann PJ, Zinner DE, Wright JC. Are methods for estimating QALYs in cost-effectiveness analyses improving? Med Decis Making 1997; 17 (4): 402–8PubMedCrossRef
16.
Zurück zum Zitat Adar R, Adar R, Cohen E, et al. Carotid endarterectomy for symptom-free stenosis: the patient’s point of view. Cardiovasc Surg 1994; 2 (5): 582–5PubMed Adar R, Adar R, Cohen E, et al. Carotid endarterectomy for symptom-free stenosis: the patient’s point of view. Cardiovasc Surg 1994; 2 (5): 582–5PubMed
17.
Zurück zum Zitat Biem HJ, Detsky AS, Armstrong PW. Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. J Gen Intern Med 1990; 5 (5): 394–401PubMedCrossRef Biem HJ, Detsky AS, Armstrong PW. Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. J Gen Intern Med 1990; 5 (5): 394–401PubMedCrossRef
18.
Zurück zum Zitat Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 2000; 39: 835–41PubMedCrossRef Duncan PW, Lai SM, Keighley J. Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 2000; 39: 835–41PubMedCrossRef
19.
Zurück zum Zitat Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996; 156 (16): 1829–36PubMedCrossRef Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 1996; 156 (16): 1829–36PubMedCrossRef
20.
Zurück zum Zitat Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation 1995; 92 (10): 2811–8PubMedCrossRef Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation 1995; 92 (10): 2811–8PubMedCrossRef
21.
Zurück zum Zitat Kellett JG, O’Riordan J. Whither the rationale for thrombolytic agent administration?: a retrospective review of traditional intuitive decision-making using a decision analysis model. Ir J Med Sci 1993; 162 (4): 133–9PubMedCrossRef Kellett JG, O’Riordan J. Whither the rationale for thrombolytic agent administration?: a retrospective review of traditional intuitive decision-making using a decision analysis model. Ir J Med Sci 1993; 162 (4): 133–9PubMedCrossRef
22.
Zurück zum Zitat Kuntz KM, Kent KC. Is carotid endarterectomy cost-effective?: an analysis of symptomatic and asymptomatic patients. Circulation 1996; 94 Suppl. 9: II194–8PubMed Kuntz KM, Kent KC. Is carotid endarterectomy cost-effective?: an analysis of symptomatic and asymptomatic patients. Circulation 1996; 94 Suppl. 9: II194–8PubMed
23.
Zurück zum Zitat Kwa VI, Limburg M, de Haan RJ. The role of cognitive impairment in the quality of life after ischaemic stroke. J Neurol 1996; 243: 599–604PubMedCrossRef Kwa VI, Limburg M, de Haan RJ. The role of cognitive impairment in the quality of life after ischaemic stroke. J Neurol 1996; 243: 599–604PubMedCrossRef
24.
Zurück zum Zitat Man-Son-Hing M, Laupacis A, O’Connor AM, et al. Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique. Med Decis Making 2000; 20: 394–403PubMedCrossRef Man-Son-Hing M, Laupacis A, O’Connor AM, et al. Patient preference-based treatment thresholds and recommendations: a comparison of decision-analytic modeling with the probability-tradeoff technique. Med Decis Making 2000; 20: 394–403PubMedCrossRef
25.
Zurück zum Zitat Matchar DB, Pauker SG. Transient ischemic attacks in a man with coronary artery disease: two strategies neck and neck. Med Decis Making 1986; 6 (4): 239–49PubMedCrossRef Matchar DB, Pauker SG. Transient ischemic attacks in a man with coronary artery disease: two strategies neck and neck. Med Decis Making 1986; 6 (4): 239–49PubMedCrossRef
26.
Zurück zum Zitat McNamara RL, Lima JA, Whelton PK, et al. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis. Ann Intern Med 1997; 127 (9): 775–87PubMed McNamara RL, Lima JA, Whelton PK, et al. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis. Ann Intern Med 1997; 127 (9): 775–87PubMed
27.
Zurück zum Zitat O’Meara III JJ, McNutt RA, Evans AT, et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330 (26): 1864–9PubMedCrossRef O’Meara III JJ, McNutt RA, Evans AT, et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330 (26): 1864–9PubMedCrossRef
28.
Zurück zum Zitat Oster G, Huse DM, Lacey MJ, et al. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Stroke 1994; 25 (6): 1149–56PubMedCrossRef Oster G, Huse DM, Lacey MJ, et al. Cost-effectiveness of ticlopidine in preventing stroke in high-risk patients. Stroke 1994; 25 (6): 1149–56PubMedCrossRef
29.
Zurück zum Zitat Patel ST, Haser PB, Korn P, et al. Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis? J Vasc Surg 1999; 30 (6): 1024–33PubMedCrossRef Patel ST, Haser PB, Korn P, et al. Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis? J Vasc Surg 1999; 30 (6): 1024–33PubMedCrossRef
30.
Zurück zum Zitat Porter PJ, Shin AY, Detsky AS, et al. Surgery versus stereotactic radiosurgery for small, operable cerebral arteriovenous malformations: a clinical and cost comparison. Neurosurgery 1997; 41 (4): 757–64PubMedCrossRef Porter PJ, Shin AY, Detsky AS, et al. Surgery versus stereotactic radiosurgery for small, operable cerebral arteriovenous malformations: a clinical and cost comparison. Neurosurgery 1997; 41 (4): 757–64PubMedCrossRef
31.
Zurück zum Zitat Samsa GP, Matchar DB, Goldstein L, et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998; 136 (4 Pt 1): 703–13PubMedCrossRef Samsa GP, Matchar DB, Goldstein L, et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 1998; 136 (4 Pt 1): 703–13PubMedCrossRef
32.
Zurück zum Zitat Samsa GP, Reutter RA, Parmigiani G, et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol 1999; 52 (3): 259–71CrossRef Samsa GP, Reutter RA, Parmigiani G, et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol 1999; 52 (3): 259–71CrossRef
33.
Zurück zum Zitat Shin AY, Porter PJ, Wallace MC, et al. Quality of life of stroke in younger individuals: utility assessment in patients with arteriovenous malformations. Stroke 1997; 28 (12): 2395–9PubMedCrossRef Shin AY, Porter PJ, Wallace MC, et al. Quality of life of stroke in younger individuals: utility assessment in patients with arteriovenous malformations. Stroke 1997; 28 (12): 2395–9PubMedCrossRef
34.
Zurück zum Zitat Solomon NA, Glick HA, Russo CJ, et al. Patient preferences for stroke outcomes. Stroke 1994; 25 (9): 1721–5PubMedCrossRef Solomon NA, Glick HA, Russo CJ, et al. Patient preferences for stroke outcomes. Stroke 1994; 25 (9): 1721–5PubMedCrossRef
35.
Zurück zum Zitat Thomson R, Parkin D, Eccles M, et al. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000; 355 (9208): 956–62PubMedCrossRef Thomson R, Parkin D, Eccles M, et al. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000; 355 (9208): 956–62PubMedCrossRef
36.
Zurück zum Zitat Kalaian HA, Raudenbush SW. A multivariate mixed linear model for meta-analysis. Psychol Methods 1996; 1 (3): 227–35CrossRef Kalaian HA, Raudenbush SW. A multivariate mixed linear model for meta-analysis. Psychol Methods 1996; 1 (3): 227–35CrossRef
37.
Zurück zum Zitat Bryk AS, Raudenbush SW. Hierarchical linear models: applications and data analysis methods. Newbury Park (CA): Sage, 1992 Bryk AS, Raudenbush SW. Hierarchical linear models: applications and data analysis methods. Newbury Park (CA): Sage, 1992
38.
Zurück zum Zitat Frost C, Clarke R, Beacon H. Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol. Stat Med 1999; (18): 1657–76 Frost C, Clarke R, Beacon H. Use of hierarchical models for meta-analysis: experience in the metabolic ward studies of diet and blood cholesterol. Stat Med 1999; (18): 1657–76
39.
Zurück zum Zitat Littell RC, Milliken GA, Stroup WW, et al. SAS system for mixed models. Cary (NC): SAS Institute Inc, 1996 Littell RC, Milliken GA, Stroup WW, et al. SAS system for mixed models. Cary (NC): SAS Institute Inc, 1996
40.
Zurück zum Zitat Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982; 30 (6): 1043–69PubMedCrossRef Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982; 30 (6): 1043–69PubMedCrossRef
41.
Zurück zum Zitat Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23 (2): 203–35PubMed Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23 (2): 203–35PubMed
Metadaten
Titel
A Meta-Analysis of Quality-of-Life Estimates for Stroke
verfasst von
Dr Tammy O. Tengs
Ting H. Lin
Publikationsdatum
01.02.2003
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 3/2003
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200321030-00004

Weitere Artikel der Ausgabe 3/2003

PharmacoEconomics 3/2003 Zur Ausgabe